AI-Powered Digital Education for Breast Cancer Radiotherapy Patients
Treatments studied
Part of Cancer, Injuries & trauma, Skin clinical trials.
This study tests a smartphone or computer-based educational program designed to help breast cancer patients who are about to start radiation therapy. The program uses artificial intelligence to provide personalized information and support during your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older with primary breast cancer
- You have finished surgery and are scheduled to start radiation therapy for the first time
- You are in overall good health and able to participate in study visits and assessments
- You speak, read, and understand Turkish fluently
- You have internet access and can use a smartphone, tablet, or computer
- You are willing to sign a consent form and participate voluntarily
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new computer-based education module created by artificial intelligence to help breast cancer patients understand their diagnosis and treatment options. The goal is to see if this tool helps patients feel more informed and prepared for their care.
This trial tests a mobile app that uses artificial intelligence to help women with early-stage breast cancer manage symptoms during their first chemotherapy. The app is in Arabic and is designed to make it easier to report how you're feeling and get support.
This study tests if a smartphone-based education program helps women who are recovering from breast reconstruction surgery after a mastectomy. If you are a Turkish speaker with a compatible smartphone, you may be able to join.
This study tests if education supported by artificial intelligence (AI) helps women recover better after breast removal surgery. If you're having a mastectomy, you may be able to join.
This study is testing a personalized digital health program to help breast cancer survivors manage side effects. It uses a smartphone app to track symptoms and offer support.
This trial tests whether an AI-powered management program can improve mental health and daily habits for people with HR+/HER2- breast cancer who are taking CDK4/6 inhibitor pills at home. It is designed to help you feel supported and stay on track with your rehabilitation plan.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.